Goldman Sachs Group Inc Seagen Inc. Put Options Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 May 14, 2024	BUY	$191.51 - $216.16 $36.2 Million - $40.8 Million	188,800 New	188,800 $40.1 Million
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $22.8 Million - $25.7 Million	118,800 Added 169.71%	188,800 $40.1 Million
Q2 2023 May 14, 2024	BUY	$187.64 - $206.25 $13.1 Million - $14.4 Million	70,000 New	70,000 $13.5 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $13.1 Million - $14.4 Million	70,000 New	70,000 $13.5 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.